Approvals/TGA/ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial

Approved

STANDARD

ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial

Lundbeck Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b21b29ae77b88f85
Product Name: ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial
Artg Id: 211150
Artg Name: ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial
Sponsor: Lundbeck Australia Pty Ltd
Company Detail Path: /organization/lundbeck-australia-pty-ltd
Artg Date: 2014-07-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a9360f8b97784d2299a020d2b13320ff.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/eec0d98989c76a77c9a4b1745900d1cc.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b21b29ae77b88f85

Type

Standard